![Bettina Cockroft](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bettina Cockroft
Direttore/Membro del Consiglio presso
ANNEXON, INC.
Patrimonio netto: 5 $ in data 31/05/2026
Profilo
Bettina M.
Cockroft is currently an Independent Director at Annexon, Inc. since 2022 and an Independent Director at CNS Pharmaceuticals, Inc. since 2023.
Formerly, served as Chief Medical Officer & Senior Vice President at Sangamo Therapeutics, Inc. from 2019 to 2023, Vice President-Clinical Research at Cytokinetics, Inc. from 2017 to 2019, and Chief Medical Officer at Auris Medical AG from 2013 to 2016.
Education includes a doctorate from the University of Genoa and an MBA from MIT Sloan School of Management.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 27/04/2026 | 1 ( 0% ) | 5 $ | 31/05/2026 | |
ANNEXON, INC. -.--% | 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Posizioni attive di Bettina Cockroft
| Società | Posizione | Inizio |
|---|---|---|
| ANNEXON, INC. | Direttore/Membro del Consiglio | 20/01/2022 |
| CNS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 08/05/2023 |
Precedenti posizioni note di Bettina Cockroft
| Società | Posizione | Fine |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 16/05/2023 |
| CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | 01/09/2019 |
Auris Medical AG
 Auris Medical AG Medical SpecialtiesHealth Technology Manufactures electronic devices for ear disorders | Direttore Tecnico/Scientifico/R&S | 01/09/2016 |
Formazione di Bettina Cockroft
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
13
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
Annexon, Inc.
 Annexon, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurodegenerative and autoimmune disorders | Health Technology |
University of Genoa
 University of Genoa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Auris Medical AG
Auris Medical AG Medical SpecialtiesHealth Technology Manufactures electronic devices for ear disorders | Health Technology |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CNS Pharmaceuticals, Inc.
 CNS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical drugs | Health Technology |
